Inventor

EBERT CHARLES D

US39 patents

⚠️ This page may combine multiple inventors who share the name “EBERT CHARLES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

EBERT CHARLES D

THERATECH INC

Transdermal drug delivery matrix for coadministering estradiol and another steroid

Apparatus and method for noninvasive blood glucose monitoring

Device for administering an active agent to the skin or mucosa

Method for reducing skin irritation associated with drug/penetration enhancer compositions

Device for administering an active agent to the skin or mucosa

Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents

Drug delivery compositions for improved stability of steroids

Methods for providing testosterone and optionally estrogen replacement therapy to women

Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels

Compositions and methods for buccal delivery of pharmaceutical agents

Buccal delivery of glucagon-like insulinotropic peptides

Transdermal delivery system with adhesive overlay and peel seal disc

Drug-containing adhesive composite transdermal delivery device

Triacetin as a penetration enhancer for transdermal delivery of a basic drug

Transmucosal delivery of macromolecular drugs

Buccal delivery of glucagon-like insulinotropic peptides

Triacetin as a penetration enhancer for transdermal delivery of a basic drug

Subsaturated transdermal drug delivery device exhibiting enhanced drug flux

Sorbitan esters as skin permeation enhancers

Sorbitan esters as skin permeation enhancers

Transmucosal delivery of macromolecular drugs

Sorbitan esters as skin permeation enhancers

Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes

Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes

WATSON LAB INC

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Compositions and methods for transdermal oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

WATSON PHARMACEUTICALS INC

Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersions

Antioxidant composition for topical/transdermal prevention and treatment of wrinkles

Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy

Transdermal delivery devices containing polydiorganosiloxane polymers to regulate adhesive properties

Compositions and methods for transdermal oxybutynin therapy

PFIZER

Chitosan compositions for controlled and prolonged release of macromolecules

CIBA GEIGY CORP

Transdermal administration of a systemic active agent to a premature neonatal infant

EBERT CHARLES D

Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy

ALLERGAN SALES LLC

Compositions and methods for unoccluded transdermal oxybutynin therapy